Moderna (WBO:MRNA) Total Stockholders Equity : €12,704 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Moderna Total Stockholders Equity?

Moderna's Total Stockholders Equity for the quarter that ended in Dec. 2023 was €12,704 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Moderna's Book Value per Share for the quarter that ended in Dec. 2023 was €33.26. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Moderna's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.09.

Moderna Total Stockholders Equity Historical Data

The historical data trend for Moderna's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moderna Total Stockholders Equity Chart

Moderna Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

1,057.33

2,105.14

12,518.33

18,052.11

12,704.12

Moderna Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial															18,052.11	17,618.04	15,643.93	12,607.34	12,704.12

Moderna (WBO:MRNA) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Moderna's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(12704.118	-	0)	/	382
	=	33.26

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Moderna's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(22.925	+	1116.906)	/	12704.118
	=	0.09

Moderna Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Moderna's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Moderna (WBO:MRNA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Moderna Inc (WBO:MRNA) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

MRNA:USA MRNA:Peru MRNA:Mexico 0QFd:UK 0A45:UK 0QF:Germany M1RN34:Brazil

Address

200 Technology Square, Cambridge, MA, USA, 02139

Website

https://www.modernatx.com

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 39 mRNA development candidates in clinical trials as of mid-2023. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.